The New York Times
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
View original source — The New York Times ↗
Related stories
CNBC
BusinessAug 26, 2026 · 1 min
Apple sets iPhone launch event for Sept. 9, first under new CEO John Ternus
CNBC
CNBC
BusinessAug 26, 2026 · 1 min
States sue to block Trump-backed USPS mail-ballot rule after Supreme Court setback
CNBC
CNA
BusinessAug 26, 2026 · 1 min
Apple sets Sept. 9 date for next iPhone launch event
CNA
The New York Times
BusinessAug 26, 2026 · 1 min
Trump Administration Wants Billion-Dollar Businesses to Qualify as ‘Small’
The New York Times